Lawyer profile
Trevor Thompson
Latham & Watkins LLP
- Firm
- Latham & Watkins LLP
- Practice
- FDA, FDA matters, FDA regulatory
- Office
- Washington, D.C.
- Active in the record
- 2023 to 2026
Deal experience
Deal types
Jurisdictions
Deals
8 announced deals in the record Latham & Watkins Advises on ADARx Pharmaceuticals’ Upsized US$446.3 Million Initial Public Offering 28 Sept 2026
Latham & Watkins Advises on Electra Therapeutics’ Upsized US$350 Million Initial Public Offering 21 Sept 2026
Latham & Watkins Advises on BlossomHill Therapeutics’ Upsized US$150 Million IPO 10 Aug 2026
Latham Advises AIR Limited in Business Combination With Cantor Equity Partners III and Nasdaq Listing 25 May 2026
Latham & Watkins Advises Nalu Medical, Inc. on Acquisition by Boston Scientific 21 Oct 2025
Latham & Watkins Advises on ANI Pharmaceuticals’ Upsized US$316.25 Million Convertible Senior Notes Offering 16 Aug 2024
Latham & Watkins Advises Nevro Corp. on Acquisition of Vyrsa™ Technologies and Secured Financing Deal from Braidwell 9 Dec 2023
Latham & Watkins Advises Cerevel Therapeutics in Acquisition by AbbVie 7 Dec 2023
Deal alerts PRO
Get an email when Trevor Thompson is named on a newly announced deal.
Alerts come as one daily email at most.
Analytics
Based on announced deals in DealDatabaseLoading analytics…
Complete deal history
Is this you?
Claim your profile to add your title, a biography and a photo, and show a verified badge. It is free.
Claim this profile